Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Cancer Glucose Assessment and Regulation Study

NCT05132244 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT05132244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05132244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Cancer Glucose Assessment and Regulation Study
Lead sponsor
British Columbia Cancer Agency
Phase
Not applicable
Overall status
Recruiting
Start date
April 16, 2024
Completion date
October 31, 2028
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hyperglycemia, pancreatic cancer, pdac - pancreatic ductal adenocarcinoma